Comedy legend George Wendt has sadly passed away at the age of 76. Known to generations of fans as Norm from Cheers, Wendt's ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.

Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.

Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.

In the near term, commercial efforts might raise the chances that new patients are prescribed Novo Nordisk’s drug, assuming ...

The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.